Stock Events

Stock Events

Aethlon Medical 

€0.175000
96
+€0.00+0% Tuesday 13:42

Statistics

Day High
0.175
Day Low
0.113
52W High
42.4
52W Low
0.113
Volume
10,000
Avg. Volume
0
Mkt Cap
92,174.6
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

13AugExpected
Next
-3.4
-3.07
-2.74
-2.4
Expected EPS
-3.4045449999999997
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
0Revenue
-6.11MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EJU.STU. It's not an investment recommendation.
Amazon
12
AMZN
NVIDIA
12
NVDA
Apple
11
AAPL
Realty Income
11
O

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Cytodyn
CYDY
Mkt Cap315.04M
CytoDyn Inc. focuses on innovative treatments for HIV and cancer, similar to Aethlon's focus on life-threatening diseases, making them direct competitors in the biotech space.
Gilead Sciences
GILD
Mkt Cap161.19B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that develops drugs for life-threatening illnesses, including viral diseases, which competes with Aethlon's Hemopurifier therapy.
Sorrento Therapeutics
SRNE
Mkt Cap385,896
Sorrento Therapeutics, Inc. works on developing therapies for cancer, autoimmune, and infectious diseases, directly competing with Aethlon's disease treatment technologies.
Novavax
NVAX
Mkt Cap1.53B
Novavax, Inc. is involved in the development of vaccines for infectious diseases, competing with Aethlon's focus on therapeutic devices for viral diseases.
Moderna
MRNA
Mkt Cap27.09B
Moderna, Inc. specializes in drug discovery and drug development based on messenger RNA, competing in the infectious disease space with Aethlon.
Inovio Pharmaceuticals
INO
Mkt Cap97.08M
Inovio Pharmaceuticals, Inc. focuses on the discovery, development, and commercialization of DNA-based immunotherapies, competing with Aethlon's therapeutic technologies.
CRISPR Therapeutics
CRSP
Mkt Cap5.25B
CRISPR Therapeutics AG specializes in gene editing technologies, which could compete with Aethlon's therapeutic approaches in treating diseases at the genetic level.
Novartis
NVS
Mkt Cap293.94B
Novartis AG is a global healthcare company that researches, develops, manufactures, and markets healthcare products, competing across a broad range of therapeutic areas including those targeted by Aethlon.

About

Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. Furthermore, Aethlon Medical maintains a collaborative partnership with the University of Pittsburgh Medical Center's Hillman Cancer Center, conducting studies pertinent to head and neck cancer. Established in 1999, the company is headquartered in San Diego, California.
Show more...
CEO
Mr. James B. Frakes M.B.A.
Employees
9
Country
United States
ISIN
US00808Y7031
WKN
000A42HQZ

Listings

MU
DE
EJU.MU
STU
DE
EJU.STU
STU
DE
EJUN.STU
BOATS
BOATS
AEMD.BOATS

0 Comments

Share your thoughts

FAQ

What is Aethlon Medical stock price today?▼
The current price of EJU.STU is €0.18 EUR — it has increased by +0% in the past 24 hours. Watch Aethlon Medical stock price performance more closely on the chart.
What is Aethlon Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Aethlon Medical stocks are traded under the ticker EJU.STU.
What is Aethlon Medical market cap?▼
Today Aethlon Medical has the market capitalization of 92,174.6
What is Aethlon Medical revenue for the last year?▼
Aethlon Medical revenue for the last year amounts to 0 EUR.
What is Aethlon Medical net income for the last year?▼
EJU.STU net income for the last year is -6.11M EUR.
How many employees does Aethlon Medical have?▼
As of August 13, 2026, the company has 9 employees.
In which sector is Aethlon Medical located?▼
Aethlon Medical operates in the Health & Wellness sector.
When did Aethlon Medical complete a stock split?▼
Aethlon Medical has not had any recent stock splits.
Where is Aethlon Medical headquartered?▼
Aethlon Medical is headquartered in San Diego, United States.